Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01894100 · ClinicalTrials.gov registry record · NA

Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT01894100: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT01894100 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01894100, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

Limb length inequality is when a person has one leg that is longer than the other. This research will look at correcting limb length inequality in adults with knee or hip symptoms. This study will examine whether ways of measuring leg length inequality in the clinic are valid and reliable, determine whether foot posture (flat foot, normal, and high arch) is related to leg length inequality, and determine whether shoe lifts are a helpful treatment for leg length inequality and knee/hip symptoms.

Primary Outcome

Western Ontario and McMasters Universities Osteoarthritis Index pain subscale is a 5 item questionnaire that asks participants to rate their pain during walking, using stairs, in bed, sitting or lying, and standing. Each item is rated by the participant as 0-4 (no pain to extreme pain). Total scores on the pain subscale range from 0 to 20 (no pain to extreme pain).

Interventions

  • DEVICE Shoe lift correction for leg length inequality

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2013-07
Est. Completion 2015-03
Phase NA

What the finished NCT01894100 record still lists

NCT01894100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Shoe lift correction for leg length inequality is the first listed.

NCT01894100 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01894100 about?

NCT01894100 is a clinical study titled "Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms". Limb length inequality is when a person has one leg that is longer than the other. This research will look at correcting limb length inequality in adults with knee or hip symptoms. This study will examine whether ways of measuring leg length inequality in the clinic are valid and reliable, determine...

What is the current status of trial NCT01894100?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2013-07. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01894100?

The interventions under investigation include: Shoe lift correction for leg length inequality (DEVICE).

Who is sponsoring clinical trial NCT01894100?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01894100's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01894100, the US trial registry maintained by the National Library of Medicine. NCT01894100 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.